As an Italy-based company primarily engaged in the research, production and distribution of industrial, pure and medicinal gases with significant involvement in the home care medical business through provision of home care services such as oxygen therapy, mechanical ventilation, and diagnosis and care of obstructive sleep apnea syndrome, SOL has established a diversified healthcare-industrial hybrid model. The company leverages digital health solutions including InfoHealth SOLution, a web platform that controls plans, coordinates, and manages all activities carried out within healthcare facilities, positioning it competitively in both traditional industrial gases and modern healthcare services.
SOL demonstrates strong fundamentals with 2024 revenue of €1.64 billion, an increase of 7.53% compared to 2023, and a diversified business model spanning industrial gases and home healthcare services. The company benefits from demographic tailwinds in aging European populations and healthcare digitization trends, supported by its proprietary InfoHealth platform. However, exposure to mature European markets and commodity-driven gas segments may limit growth acceleration.
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.
Open report →